tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Guolian Minsheng Faces Major Litigation Over Securities Misrepresentation

Story Highlights
Guolian Minsheng Faces Major Litigation Over Securities Misrepresentation

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Guolian Securities Co., Ltd. Class H ( (HK:1456) ) has provided an update.

Guolian Minsheng Investment Banking, a subsidiary of Guolian Securities Co., Ltd., is involved in a significant litigation case concerning allegations of securities misrepresentation. The lawsuit, filed by 1,618 investors, claims that misrepresentations by Shandong Longlive Bio-Technology Co., Ltd. and associated parties, including Guolian Minsheng, led to substantial financial losses. The plaintiffs are seeking compensation for these losses, asserting that the defendants should be held jointly responsible for the damages incurred.

More about Guolian Securities Co., Ltd. Class H

Guolian Securities Co., Ltd. Class H operates in the financial services industry, primarily focusing on investment banking and securities services. The company serves a diverse range of clients, providing financial advisory, underwriting, and brokerage services.

Average Trading Volume: 29,993,987

Technical Sentiment Signal: Buy

Current Market Cap: HK$73B

Learn more about 1456 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1